Inhibitor Therapeutics's total assets for Q were $6.45M, a decrease of -10.06% from the previous quarter. INTI total liabilities were $3.04M for the fiscal quarter, a 0.30% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.